ADCs & Cancer Immunotherapy Summit




Date: February 25 - 26, 2016

Location: Vienna, Austria

This innovative B2B event will enable the participants to learn about protein modeling development and engineering advances, preclinical and clinical improvements, current ADC linker chemistry- better linker design for future generations, improving preclinical and clinical translation and creating strong and scalable processes.

Click here to visit the event website.

Catalent Presentation

Date: Friday, February 26, 2016 
Time: 10:20 am

Title: "Site-Specific ADC Generation Using SMARTag™ Technology"

  • Enabling precise & programmable site-specific chemical protein modification against a number of different antigens/targets
  • Novel conjugation chemistry for ADCs with enhanced stability & increased DAR
  • Linker chemistry that optimizes the potency of the cytotoxic payload

Speaker: David Rabuka, Global Head of R&D, Chemical Biology Catalent Pharma Solutions

お問い合わせ

    東京オフィス
    〒107‐0052
    東京都港区赤坂4−9−17
    T (03) 3470-2311
    F (03) 3408-5554

    掛川工場
    〒436‐0341
    静岡県掛川市倉真1656
    T(0537) 29-1131